| PRTN3 |
PRTN3, MBN: Myeloblastin precursor |
KLK13 |
KLK13, KLKL4: Kallikrein-13 precursor |
1.597 |
Evidence |
|
| CDH3 |
CDH3, CDHP: Cadherin-3 precursor |
CDH9 |
IPI00655756 |
1.597 |
Evidence |
|
| CDH3 |
CDH3, CDHP: Cadherin-3 precursor |
CDH7 |
CDH7, CDH7L1: Cadherin-7 precursor |
1.597 |
Evidence |
|
| CDH3 |
CDH3, CDHP: Cadherin-3 precursor |
CDH5 |
CDH5: Cadherin-5 precursor |
1.597 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
DSC3 |
DSC3, DSC4: Desmocollin-3 precursor |
1.597 |
Evidence |
|
| CDH2 |
CDH2, CDHN, NCAD: Cadherin-2 precursor |
CDH3 |
CDH3, CDHP: Cadherin-3 precursor |
1.597 |
Evidence |
|
| ATF3 |
ATF3: Cyclic AMP-dependent transcription factor ATF-3 |
DDIT3 |
DDIT3, CHOP, GADD153: DNA damage-inducible transcript 3 |
1.597 |
Evidence |
|
| CTRB1 |
CTRB1, CTRB: Chymotrypsinogen B precursor |
KLK6 |
KLK6, PRSS18, PRSS9: Kallikrein-6 precursor |
1.597 |
Evidence |
|
| CTRB1 |
CTRB1, CTRB: Chymotrypsinogen B precursor |
PRTN3 |
PRTN3, MBN: Myeloblastin precursor |
1.597 |
Evidence |
|
| CTRB1 |
CTRB1, CTRB: Chymotrypsinogen B precursor |
KLK2 |
KLK2: Kallikrein-2 precursor |
1.597 |
Evidence |
|
| RPA2 |
RPA2, REPA2, RPA32, RPA34: Replication protein A 32 kDa subunit |
RPA4 |
RPA4: Replication protein A 30 kDa subunit |
1.597 |
Evidence |
|
| HLA-DOB |
HLA-DOB: HLA class II histocompatibility antigen, DO beta chain precursor |
CD302 |
CD302, CLEC13A, DCL1, KIAA0022: CD302 antigen precursor |
1.597 |
Evidence |
|
| HAPLN1 |
HAPLN1, CRTL1: Hyaluronan and proteoglycan link protein 1 precursor |
ADAMTS5 |
ADAMTS5, ADAMTS11, ADMP2: ADAMTS-5 precursor |
1.597 |
Evidence |
|
| ACR |
ACR, ACRS: Acrosin precursor |
KLK1 |
KLK1: Kallikrein-1 precursor |
1.597 |
Evidence |
|
| ACR |
ACR, ACRS: Acrosin precursor |
KLK2 |
KLK2: Kallikrein-2 precursor |
1.597 |
Evidence |
|
| RAP2A |
RAP2A: Ras-related protein Rap-2a precursor |
IRS4 |
IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 |
1.597 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
FBLN2 |
FBLN2: Fibulin-2 precursor |
1.597 |
Evidence |
|
| CD14 |
CD14: Monocyte differentiation antigen CD14 precursor |
IL1RAPL1 |
IL1RAPL1, OPHN4: X-linked interleukin-1 receptor accessory protein-like 1 precur |
1.597 |
Evidence |
|
| CTSG |
CTSG: Cathepsin G precursor |
KLK2 |
KLK2: Kallikrein-2 precursor |
1.597 |
Evidence |
|
| ELA2 |
ELA2: Leukocyte elastase precursor |
ELA1 |
ELA1: Elastase-1 precursor |
1.597 |
Evidence |
|
| ELA2 |
ELA2: Leukocyte elastase precursor |
KLK13 |
KLK13, KLKL4: Kallikrein-13 precursor |
1.597 |
Evidence |
|
| ELA2 |
ELA2: Leukocyte elastase precursor |
KLK2 |
KLK2: Kallikrein-2 precursor |
1.597 |
Evidence |
|
| ELA2 |
ELA2: Leukocyte elastase precursor |
CTRB1 |
CTRB1, CTRB: Chymotrypsinogen B precursor |
1.597 |
Evidence |
|
| NGFR |
NGFR, TNFRSF16: Tumor necrosis factor receptor superfamily member 16 precursor |
TNFRSF4 |
TNFRSF4, TXGP1L: Tumor necrosis factor receptor superfamily member 4 precursor |
1.597 |
Evidence |
|
| MAS1 |
MAS1, MAS: MAS proto-oncogene |
ADORA2B |
ADORA2B: Adenosine receptor A2b |
1.597 |
Evidence |
|